Author/Authors :
Algin, O. Department of Radiology - Atatürk Training and Research Hospital - National Magnetic Resonance Research Center, Bilkent, Ankara, Turkey , Taskapilioglu, O. Department of Neurology - Uludag University Medical Faculty, Gorukle, Bursa, Turkey , Ocakoglu, G. Department of Biostatistics - Uludag University Medical Faculty, Gorukle, Bursa, Turkey , Yurtogullari, S. Department of Neurology - Uludag University Medical Faculty, Gorukle, Bursa, Turkey , Hakyemez, B. Department of Neurology - Uludag University Medical Faculty, Gorukle, Bursa, Turkey
Abstract :
Background/Objective: In this study, our purpose was to evaluate the thalamic magnetic
resonance (MR) spectroscopic changes in multiple sclerosis (MS) patients.
Patients and Methods: Forty-three relapsing-remitting MS (RRMS) patients and 23 control
subjects were included in this study. Routine brain MR and MR spectroscopy (MRS) using single
voxel technique were carried out in all the patients and the controls. The N-Acetylaspartate (NAA),
choline (Cho) and creatine (Cr) peaks were calculated. The thalamic relative metabolite ratios
of the RRMS patients were compared to those of the control subjects by using the statistical
measures (Mann-Whitney U test). The level of statistical significance was set at 0.05.
Results: The thalamic NAA/Cr and NAA/Cho ratios were lower while the thalamic Cho/Cr ratio
was higher in the MS patients than those of the control subjects. But these differences in the
spectroscopic relative metabolite ratios were not statistically significant between the groups
(p=0.34, p=0.22 and p=0.1, respectively).
Conclusion: The spectroscopic relative metabolite ratios were of limited value in determining
the presence of metabolic changes in the deep grey matter of MS patients. New studies about the
presence of the deep grey matter damage in MS patients are necessary.
Keywords :
Multiple Sclerosis , Brain Metabolites , Magnetic Resonance Spectroscopy , Neuronal Loss , Thalamu